SEC Says Biotech Boss Conned Investors Over COVID-19 Test
The U.S. Securities and Exchange Commission filed suit in California federal court Friday against a top executive of biotechnology company Arrayit Corp. who it says conned investors into believing the company...To view the full article, register now.
Already a subscriber? Click here to view full article